{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T06:05:54Z","timestamp":1792908354302,"version":"4.5.0"},"reference-count":87,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,8]]},"DOI":"10.4269\/ajtmh.19-0846","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T07:00:51Z","timestamp":1587452451000},"page":"378-393","source":"Crossref","is-referenced-by-count":23,"title":["Liver Enzyme Elevations in Plasmodium falciparum Volunteer Infection Studies: Findings and Recommendations"],"prefix":"10.4269","volume":"103","author":[{"given":"Mohamed Farouk","family":"Chughlay","sequence":"first","affiliation":[{"name":"Medicines for Malaria Venture, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Akakpo","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Odedra","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Csermak-Renner","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhadj","family":"Djeriou","sequence":"additional","affiliation":[{"name":"Sanofi, Gentilly, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Winnips","sequence":"additional","affiliation":[{"name":"Novartis Pharma AG, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Leboulleux","sequence":"additional","affiliation":[{"name":"Sanofi, Gentilly, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya H.","family":"Gaur","sequence":"additional","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Dennis","family":"Shanks","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McCarthy","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Chalon","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1128\/AAC.02883-15","article-title":"Linking murine and human Plasmodium falciparum challenge models in a translational path for antimalarial drug development","volume":"60","author":"McCarthy","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"b2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/toxsci\/kfy270","article-title":"Today\u2019s challenges to de-risk and predict drug safety in human \u201cmind-the-gap\u201d","volume":"167","author":"Weaver","year":"2019","journal-title":"Toxicol Sci"},{"key":"b3","volume-title":"Guidance for Industry: Drug-Induced Liver Injury: Premarketing Clinical valuation","year":"2009"},{"key":"b4","doi-asserted-by":"crossref","first-page":"e21914","DOI":"10.1371\/journal.pone.0021914","article-title":"A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs","volume":"6","author":"McCarthy","year":"2011","journal-title":"PLoS One"},{"key":"b5","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI98012","article-title":"A controlled human malaria infection model enabling evaluation of transmission-blocking interventions","volume":"128","author":"Collins","year":"2018","journal-title":"J Clin Invest"},{"key":"b6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4269\/ajtmh.1997.57.495","article-title":"Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines","volume":"57","author":"Cheng","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"b7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1475-2875-10-48","article-title":"A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers","volume":"10","author":"Rockett","year":"2011","journal-title":"Malar J"},{"key":"b8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/bmm.12.107","article-title":"Circulating miR-122 as a potential biomarker of liver disease","volume":"7","author":"Laterza","year":"2013","journal-title":"Biomark Med"},{"key":"b9","volume-title":"WHO Handbook for Reporting Results of Cancer Treatment","year":"1979"},{"key":"b10","first-page":"CD010927","article-title":"Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria","author":"Zani","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"b11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.2007.03001.x","article-title":"Muscular exercise can cause highly pathological liver function tests in healthy men","volume":"65","author":"Pettersson","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"b12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0035-1567829","article-title":"Genome-wide association studies in drug-induced liver injury: step change in understanding the pathogenesis","volume":"35","author":"Aithal","year":"2015","journal-title":"Semin Liver Dis"},{"key":"b13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/jhg.2016.10","article-title":"NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis","volume":"61","author":"Yuliwulandari","year":"2016","journal-title":"J Hum Genet"},{"key":"b14","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/liv.12836","article-title":"Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice","volume":"35","author":"Aithal","year":"2015","journal-title":"Liver Int"},{"key":"b15","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"b16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/apt.15153","article-title":"Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis","volume":"49","author":"Regev","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"b17","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0960327113512860","article-title":"Female gender as a susceptibility factor for drug-induced liver injury","volume":"33","author":"Amacher","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"b18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/17425255.2010.503706","article-title":"Predicting and preventing acute drug-induced liver injury: what\u2019s new in 2010?","volume":"6","author":"Liss","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"b19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2141.2009.07664.x","article-title":"Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection","volume":"145","author":"de Mast","year":"2009","journal-title":"Br J Haematol"},{"key":"b20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2875-13-106","article-title":"Liver changes in severe Plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression","volume":"13","author":"Viriyavejakul","year":"2014","journal-title":"Malar J"},{"key":"b21","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1440-1746.2005.03884.x","article-title":"Jaundice in malaria","volume":"20","author":"Anand","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"b22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4269\/ajtmh.17-0754","article-title":"The dynamics of liver function test abnormalities following malaria infection: a retrospective observational study","volume":"98","author":"Woodford","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"b23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ebiom.2018.09.018","article-title":"Liver injury in uncomplicated malaria is an overlooked phenomenon: an observational study","volume":"36","author":"Reuling","year":"2018","journal-title":"EBioMedicine"},{"key":"b24","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.108.026195","article-title":"Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure","volume":"37","author":"James","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"b25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2050-6511-15-39","article-title":"A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration","volume":"15","author":"Heard","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"b26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.296.1.87","article-title":"Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial","volume":"296","author":"Watkins","year":"2006","journal-title":"JAMA"},{"key":"b27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/15287390903249057","article-title":"Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity","volume":"73","author":"Maddox","year":"2010","journal-title":"J Toxicol Environ Health A"},{"key":"b28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cbi.2004.09.002","article-title":"Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor","volume":"150","author":"Ganey","year":"2004","journal-title":"Chem Biol Interact"},{"key":"b29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/toxsci\/kfr266","article-title":"Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha","volume":"125","author":"Lu","year":"2012","journal-title":"Toxicol Sci"},{"key":"b30","first-page":"CD006404","article-title":"Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria","volume":"1","author":"Pryce","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"b31","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","article-title":"Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"b32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4269\/ajtmh.1984.33.767","article-title":"Evaluation of the 4-pyridinemethanol WR 180,409 (enpiroline) in the treatment of induced Plasmodium falciparum infections in healthy, non-immune subjects","volume":"33","author":"Cosgriff","year":"1984","journal-title":"Am J Trop Med Hyg"},{"key":"b33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4269\/ajtmh.1982.31.1075","article-title":"Evaluation of the antimalarial activity of the phenanthrenemethanol halofantrine (WR 171,669)","volume":"31","author":"Cosgriff","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"b34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.4269\/ajtmh.1976.25.769","article-title":"Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669","volume":"25","author":"Rinehart","year":"1976","journal-title":"Am J Trop Med Hyg"},{"key":"b35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/AAC.3.2.207","article-title":"A phenanthrene methanol (WR 33063) for treatment of acute malaria","volume":"3","author":"Arnold","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"key":"b36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/00034983.1967.11686504","article-title":"Acquired decrease in sensitivity to quinine observed during studies with a strain of chloroquine-resistant Plasmodium falciparum","volume":"61","author":"McNamara","year":"1967","journal-title":"Ann Trop Med Parasitol"},{"key":"b37","first-page":"625","article-title":"Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum","volume":"38","author":"Rieckmann","year":"1968","journal-title":"Bull World Health Organ"},{"key":"b38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4269\/ajtmh.1971.20.811","article-title":"Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum","volume":"20","author":"Rieckmann","year":"1971","journal-title":"Am J Trop Med Hyg"},{"key":"b39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4269\/ajtmh.1978.27.226","article-title":"The influence of acetylator phenotype on the response to sulfalene in individuals with chloroquine-resistant falciparum malaria","volume":"27","author":"Williams","year":"1978","journal-title":"Am J Trop Med Hyg"},{"key":"b40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4269\/ajtmh.1975.24.734","article-title":"Acetylator phenotype and response of individuals infected with a chloroquine-resistant strain of Plasmodium falciparum to sulfalene and pyrimethamine","volume":"24","author":"Williams","year":"1975","journal-title":"Am J Trop Med Hyg"},{"key":"b41","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1105787","article-title":"Mefloquine (WR 142,490) in the treatment of human malaria","volume":"190","author":"Trenholme","year":"1975","journal-title":"Science"},{"key":"b42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/AAC.3.2.214","article-title":"A quinoline methanol (WR 30090) for treatment of acute malaria","volume":"3","author":"Martin","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"key":"b43","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1749-6632.1970.tb45625.x","article-title":"Infection with chloroquine-resistant Plasmodium falciparum in man: prepatent periods, incubation periods, and relationships between parasitemia and the onset of fever in nonimmune persons","volume":"174","author":"Powell","year":"1970","journal-title":"Ann N Y Acad Sci"},{"key":"b44","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1086\/513990","article-title":"Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge","volume":"175","author":"Church","year":"1997","journal-title":"J Infect Dis"},{"key":"b45","first-page":"52","article-title":"Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes","volume":"63","author":"Verhage","year":"2005","journal-title":"Neth J Med"},{"key":"b46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/518510","article-title":"Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update","volume":"196","author":"Epstein","year":"2007","journal-title":"J Infect Dis"},{"key":"b47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/infdis\/jis355","article-title":"Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers","volume":"206","author":"Roestenberg","year":"2012","journal-title":"J Infect Dis"},{"key":"b48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41541-018-0084-2","article-title":"Safety and efficacy of novel malaria vaccine regimens of RTS,S\/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP","volume":"3","author":"Rampling","year":"2018","journal-title":"NPJ Vaccines"},{"key":"b49","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/AAC.42.5.1293","article-title":"Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial","volume":"42","author":"Brueckner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"b50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4269\/ajtmh.1999.60.831","article-title":"Prophylactic activity of atovaquone against Plasmodium falciparum in humans","volume":"60","author":"Shapiro","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"b51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0035-9203(01)90206-8","article-title":"Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model","volume":"95","author":"Berman","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"b52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/cid\/cir770","article-title":"Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model","volume":"54","author":"Deye","year":"2012","journal-title":"Clin Infect Dis"},{"key":"b53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4269\/ajtmh.1972.21.138","article-title":"The chemoprophylactic use of diformyl diaminodiphenyl sulfone (DFD) in falciparum malaria","volume":"21","author":"Willerson","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"b54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4269\/ajtmh.1972.21.857","article-title":"Effects of minocycline against chloroquine-resistant falciparum malaria","volume":"21","author":"Willerson","year":"1972","journal-title":"Am J Trop Med Hyg"},{"key":"b55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4269\/ajtmh.2009.80.528","article-title":"Phase I\/II evaluation of the prophylactic antimalarial activity of pafuramidine in healthy volunteers challenged with Plasmodium falciparum sporozoites","volume":"80","author":"Nyunt","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"b56","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/milmed\/134.9.802","article-title":"Gametocytocidal and sporontocidal effects of primaquine upon two strains of Plasmodium falciparum","volume":"134","author":"Rieckmann","year":"1969","journal-title":"Mil Med"},{"key":"b57","first-page":"375","article-title":"Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria","volume":"51","author":"Rieckmann","year":"1974","journal-title":"Bull World Health Organ"},{"key":"b58","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/jix613","article-title":"A randomized trial of the prophylactic activity of DSM265 against pre-erythrocytic Plasmodium falciparum controlled human malaria infection by mosquito bites and direct venous inoculation","volume":"217","author":"Murphy","year":"2017","journal-title":"J Infect Dis"},{"key":"b59","doi-asserted-by":"crossref","first-page":"e31549","DOI":"10.7554\/eLife.31549","article-title":"A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model","volume":"7","author":"Reuling","year":"2018","journal-title":"Elife"},{"key":"b60","doi-asserted-by":"crossref","first-page":"e109654","DOI":"10.1371\/journal.pone.0109654","article-title":"Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naive subjects at a new facility for sporozoite challenge","volume":"9","author":"Talley","year":"2014","journal-title":"PLoS One"},{"key":"b61","doi-asserted-by":"crossref","first-page":"e68969","DOI":"10.1371\/journal.pone.0068969","article-title":"Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection","volume":"8","author":"Laurens","year":"2013","journal-title":"PLoS One"},{"key":"b62","doi-asserted-by":"crossref","first-page":"e13490","DOI":"10.1371\/journal.pone.0013490","article-title":"Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial","volume":"5","author":"Lyke","year":"2010","journal-title":"PLoS One"},{"key":"b63","doi-asserted-by":"crossref","first-page":"e38434","DOI":"10.1371\/journal.pone.0038434","article-title":"Comparison of clinical and parasitological data from controlled human malaria infection trials","volume":"7","author":"Roestenberg","year":"2012","journal-title":"PLoS One"},{"key":"b64","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4269\/ajtmh.2004.71.2.0700196","article-title":"Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction","volume":"71","author":"Hermsen","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"b65","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4269\/ajtmh.18-0194","article-title":"Controlled Human malaria infection with graded numbers of Plasmodium falciparum NF135.C10- or NF166.C8-infected mosquitoes","volume":"99","author":"Langenberg","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"b66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12936-015-0817-x","article-title":"Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naive volunteers: effect of injection volume and dose on infectivity rates","volume":"14","author":"Gomez-Perez","year":"2015","journal-title":"Malar J"},{"key":"b67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.2012.12-0613","article-title":"Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites","volume":"88","author":"Roestenberg","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"b68","doi-asserted-by":"crossref","first-page":"e65960","DOI":"10.1371\/journal.pone.0065960","article-title":"Optimising controlled human malaria infection studies using cryopreserved P. falciparum parasites administered by needle and syringe","volume":"8","author":"Sheehy","year":"2013","journal-title":"PLoS One"},{"key":"b69","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.14-0119","article-title":"Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites","volume":"91","author":"Shekalaghe","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"b70","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4269\/ajtmh.15-0621","article-title":"Safety, immunogenicity, and protective efficacy of intradermal immunization with aseptic, purified, cryopreserved Plasmodium falciparum sporozoites in volunteers under chloroquine prophylaxis: a randomized controlled trial","volume":"94","author":"Bastiaens","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"b71","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1473-3099(17)30139-1","article-title":"DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection","volume":"17","author":"Sulyok","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"b72","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fmicb.2014.00686","article-title":"Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection","volume":"5","author":"Hodgson","year":"2014","journal-title":"Front Microbiol"},{"key":"b73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12936-015-0628-0","article-title":"Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres","volume":"14","author":"Mordmuller","year":"2015","journal-title":"Malar J"},{"key":"b74","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4269\/ajtmh.15-0341","article-title":"Optimizing intradermal administration of cryopreserved Plasmodium falciparum sporozoites in controlled human malaria infection","volume":"93","author":"Lyke","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"b75","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/IAI.03069-14","article-title":"Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection","volume":"83","author":"Obiero","year":"2015","journal-title":"Infect Immun"},{"key":"b76","doi-asserted-by":"crossref","first-page":"e00541","DOI":"10.1128\/IAI.00541-18","article-title":"Mosquito-bite induced controlled human malaria infection with P. vivax or P. falciparum generates immune responses to homologous and heterologous preerythrocytic and erythrocytic antigens","volume":"87","author":"Hall","year":"2018","journal-title":"Infect Immun"},{"key":"b77","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4269\/ajtmh.17-0343","article-title":"Impact of sickle cell trait and naturally acquired immunity on uncomplicated malaria after controlled human malaria infection in adults in Gabon","volume":"98","author":"Lell","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"b78","doi-asserted-by":"crossref","first-page":"e00587-18","DOI":"10.1128\/IAI.00587-18","article-title":"Controlled infection immunization using delayed death drug treatment elicits protective immune responses to blood-stage malaria parasites","volume":"87","author":"Low","year":"2019","journal-title":"Infect Immun"},{"key":"b79","first-page":"709","article-title":"Mildly elevated liver transaminase levels: causes and evaluation","volume":"96","author":"Oh","year":"2017","journal-title":"Am Fam Physician"},{"key":"b80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0035-9203(95)90087-X","article-title":"Fever in uncomplicated Plasmodium falciparum malaria: randomized double-\u2018blind\u2019 comparison of ibuprofen and paracetamol treatment","volume":"89","author":"Krishna","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"b81","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.2042-7158.2011.01406.x","article-title":"NSAIDs: take with food or after fasting?","volume":"64","author":"Rainsford","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"b82","volume-title":"Drug record: Ibuprofen"},{"key":"b83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5414\/CN109212","article-title":"Drug-induced kidney injury: a large case series from the Berlin case-control surveillance study","volume":"89","author":"Douros","year":"2018","journal-title":"Clin Nephrol"},{"key":"b84","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"key":"b85","volume-title":"Letter of Support for Drug-Induced Liver Injury (DILI) Biomarker","year":"2016"},{"key":"b86","volume-title":"Letter of Support for Drug-Induced Liver Injury (DJU) Biomarker(s)","year":"2016"},{"key":"b87","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s40264-014-0184-5","article-title":"Methodology to assess clinical liver safety data","volume":"37","author":"Merz","year":"2014","journal-title":"Drug Saf"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T17:39:51Z","timestamp":1611769191000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.19-0846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7,8]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.19-0846","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]}}}